TNGX EBITDA Margin
Tango Therapeutics Inc · EBITDA Margin
TNGX EBITDA Margin
Latest reported-226.46%period ending
TNGX EBITDA Margin (-58.90% → -226.46%)
Annual ebitda margin
High-resolution chart · PNG
TNGX ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -159.1899% | |
| -303.2993% | |
| -271.5662% | |
| -428.4553% | |
| -154.0036% | |
| -669.4619% | |
| -58.903% |